Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis
出版年份 2023 全文链接
标题
Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis
作者
关键词
-
出版物
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245852211508
出版商
SAGE Publications
发表日期
2023-02-01
DOI
10.1177/13524585221150881
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study
- (2022) Gabriel Bsteh et al. EUROPEAN JOURNAL OF NEUROLOGY
- Associations of Chronic Kidney Disease With Dementia Before and After TIA and Stroke
- (2022) Dearbhla M. Kelly et al. NEUROLOGY
- Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
- (2022) Marton König et al. JAMA Neurology
- Safety of Sinopharm vaccine for people with Multiple Sclerosis: Study of adverse reactions and disease activity
- (2022) Aryan Kavosh et al. Multiple Sclerosis and Related Disorders
- An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
- (2022) Kairat Tabynov et al. npj Vaccines
- Vaccination and immunotherapies in neuroimmunological diseases
- (2022) Alexander Winkelmann et al. Nature Reviews Neurology
- A one year follow of patients with multiple sclerosis during COVID-19 pandemic: A cross-sectional study in Qom province, Iran
- (2022) Sepideh Paybast et al. Multiple Sclerosis and Related Disorders
- Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis
- (2022) Ethel Ciampi et al. Multiple Sclerosis and Related Disorders
- Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
- (2022) Agata Czarnowska et al. Vaccines
- Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
- (2022) Rocco Capuano et al. JOURNAL OF NEUROLOGY
- Quantitative and Qualitative Features of Acute Phase-Adverse Events Following SARS-CoV-2 Vaccination in a Large Sample of People with Multiple Sclerosis
- (2022) E. Tavazzi et al. Multiple Sclerosis and Related Disorders
- COVID-19 vaccination in people with multiple sclerosis, real-life experience
- (2022) Raed Alroughani et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
- (2022) Lingyao Kong et al. Multiple Sclerosis and Related Disorders
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
- (2021) K. Allen-Philbey et al. Multiple Sclerosis and Related Disorders
- Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
- (2021) Itay Lotan et al. EUROPEAN JOURNAL OF NEUROLOGY
- mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
- (2021) Massimiliano Di Filippo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV
- (2021) Mohammad Ali Sahraian et al. VACCINE
- Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
- (2021) Jihad Inshasi et al. Neurology and Therapy
- Autoimmune phenomena following SARS-CoV-2 vaccination
- (2021) Yuval Ishay et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- First COVID-19 DNA vaccine approved, others in hot pursuit
- (2021) Cormac Sheridan NATURE BIOTECHNOLOGY
- Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
- (2021) Fioravante Capone et al. Neurotherapeutics
- Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data
- (2021) Samantha Epstein et al. Multiple Sclerosis and Related Disorders
- COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
- (2021) Farren Basil Shaw Briggs et al. Neurology-Neuroimmunology & Neuroinflammation
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- Closing the Gap between Methodologists and End-Users:Ras a Computational Back-End
- (2015) Byron C. Wallace et al. Journal of Statistical Software
- Immunizations and risk of multiple sclerosis: systematic review and meta-analysis
- (2011) Mauricio F. Farez et al. JOURNAL OF NEUROLOGY
- Assessing changes in relapse rates in multiple sclerosis
- (2010) Seidu Inusah et al. Multiple Sclerosis Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search